NIH St. John's wort trial
This article was originally published in The Tan Sheet
Executive Summary
NIH clinical trial studying St. John's wort's efficacy in treating depression has enrolled about one-fourth of the expected 330 patients. The study, led by principle investigator Jonathan Davidson, MD, Duke University, is being funded by NIH's National Center for Complementary & Alternative Medicine, National Institute of Mental Health and Office of Dietary Supplements. Recruitment was delayed due to a problem with Duke's Review Board research review procedures ("The Tan Sheet" May 17, In Brief)
You may also be interested in...
Complementary Therapies Availability Poses Threat To Controlled Liver Trials
Widespread use of alternative medicines for chronic liver disease will complicate randomized, controlled trials of those substances, former NIH Office of Alternative Medicine Director Wayne Jonas, MD, told a National Institutes of Health workshop on "Complementary and Alternative Medicine in Chronic Liver Disease" Aug. 23.
Complementary Therapies Availability Poses Threat To Controlled Liver Trials
Widespread use of alternative medicines for chronic liver disease will complicate randomized, controlled trials of those substances, former NIH Office of Alternative Medicine Director Wayne Jonas, MD, told a National Institutes of Health workshop on "Complementary and Alternative Medicine in Chronic Liver Disease" Aug. 23.
Complementary Therapies Availability Poses Threat To Controlled Liver Trials
Widespread use of alternative medicines for chronic liver disease will complicate randomized, controlled trials of those substances, former NIH Office of Alternative Medicine Director Wayne Jonas, MD, told a National Institutes of Health workshop on "Complementary and Alternative Medicine in Chronic Liver Disease" Aug. 23.